FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119498948> ?p ?o ?g. }

• W2119498948 endingPage "749" @default.
• W2119498948 startingPage "741" @default.
• W2119498948 abstract "BACKGROUND: Excision followed by radiofrequency ablation (eRFA) is an intraoperative method that uses intracavitary hyperthermia to create an additional tumor-free zone around the lumpectomy cavity in breast cancer patients. We hypothesized that eRFA after lumpectomy for invasive breast cancer could reduce the need for re-excision for close margins as well as potentially maintain local control without the need for radiation. STUDY DESIGN: This prospective phase II institutional review board-approved study was conducted from March 2004 to April 2010. A standard lumpectomy was performed, then the RFA probe was deployed 1 cm circumferentially into the walls of the lumpectomy cavity and maintained at 100°C for 15 minutes. Validated Doppler sonography was used to intraoperatively determine adequacy of ablation. RESULTS: One hundred patients were accrued to the trial, with an average age of 65.02 years ± 10.0 years. The stages were Tis (n = 30); T1mic (n = 1); T1a (n = 9); T1b (n = 27); T1c (n = 22); T2 (n = 10); and T3 (n = 1). Grades were I (n = 48); II (n = 29); and III (n = 23). Seventy-eight subjects had margins >2 mm (negative), 22 patients had margins ≤ 2 mm, of which 12 were close and 3 focally positive, which, at our institution, would have required re-excision (only 1 patient in this group had re-excision). There were 6% postoperative complications, and 24 patients received radiation therapy (XRT). During the study mean follow-up period of 62 months ± 24 months (68-month median follow-up) in patients not treated with XRT, there were 2 in-site tumor recurrences treated with aromitase inhibitor, 3 biopsy entrance site recurrences treated with excision and XRT to conserve the breast, and 2 recurrences elsewhere and 1 contralateral recurrence; all 3 treated with mastectomy. CONCLUSIONS: Long-term follow-up suggests that eRFA may reduce the need for re-excision for close or focally positive margins in breast cancer patients, and eRFA may be a valuable tool for treating favorable patients who desire lumpectomy and either cannot or do not want radiation. A multicenter trial has been initiated based on these results." @default.
• W2119498948 created "2016-06-24" @default.
• W2119498948 creator A5000495712 @default.
• W2119498948 creator A5002579268 @default.
• W2119498948 creator A5004324395 @default.
• W2119498948 creator A5005464769 @default.
• W2119498948 creator A5014927451 @default.
• W2119498948 creator A5016602100 @default.
• W2119498948 creator A5044425154 @default.
• W2119498948 creator A5051483672 @default.
• W2119498948 creator A5052851513 @default.
• W2119498948 creator A5053005053 @default.
• W2119498948 creator A5056409417 @default.
• W2119498948 creator A5091019309 @default.
• W2119498948 date "2014-04-01" @default.
• W2119498948 modified "2023-09-26" @default.
• W2119498948 title "Long-Term Results of Phase II Ablation after Breast Lumpectomy Added to Extend Intraoperative Margins (ABLATE l) Trial" @default.
• W2119498948 cites W1969850376 @default.
• W2119498948 cites W1979300931 @default.
• W2119498948 cites W1982853521 @default.
• W2119498948 cites W1993760343 @default.
• W2119498948 cites W2000427523 @default.
• W2119498948 cites W2005301907 @default.
• W2119498948 cites W2006828850 @default.
• W2119498948 cites W2019661342 @default.
• W2119498948 cites W2043468165 @default.
• W2119498948 cites W2051473853 @default.
• W2119498948 cites W2052577752 @default.
• W2119498948 cites W2059184068 @default.
• W2119498948 cites W2063862444 @default.
• W2119498948 cites W2067420088 @default.
• W2119498948 cites W2073698901 @default.
• W2119498948 cites W2083503573 @default.
• W2119498948 cites W2083825568 @default.
• W2119498948 cites W2093610897 @default.
• W2119498948 cites W2103608035 @default.
• W2119498948 cites W2103997508 @default.
• W2119498948 cites W2119579281 @default.
• W2119498948 cites W2130746306 @default.
• W2119498948 cites W2133494786 @default.
• W2119498948 cites W2146522000 @default.
• W2119498948 cites W2149455283 @default.
• W2119498948 cites W2149955179 @default.
• W2119498948 cites W2169863920 @default.
• W2119498948 cites W2239673439 @default.
• W2119498948 cites W2292080056 @default.
• W2119498948 cites W2785593260 @default.
• W2119498948 cites W2800860148 @default.
• W2119498948 cites W3150212756 @default.
• W2119498948 doi "https://doi.org/10.1016/j.jamcollsurg.2013.12.032" @default.
• W2119498948 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24655863" @default.
• W2119498948 hasPublicationYear "2014" @default.
• W2119498948 type Work @default.
• W2119498948 sameAs 2119498948 @default.
• W2119498948 citedByCount "10" @default.
• W2119498948 countsByYear W21194989482014 @default.
• W2119498948 countsByYear W21194989482015 @default.
• W2119498948 countsByYear W21194989482016 @default.
• W2119498948 countsByYear W21194989482018 @default.
• W2119498948 countsByYear W21194989482022 @default.
• W2119498948 crossrefType "journal-article" @default.
• W2119498948 hasAuthorship W2119498948A5000495712 @default.
• W2119498948 hasAuthorship W2119498948A5002579268 @default.
• W2119498948 hasAuthorship W2119498948A5004324395 @default.
• W2119498948 hasAuthorship W2119498948A5005464769 @default.
• W2119498948 hasAuthorship W2119498948A5014927451 @default.
• W2119498948 hasAuthorship W2119498948A5016602100 @default.
• W2119498948 hasAuthorship W2119498948A5044425154 @default.
• W2119498948 hasAuthorship W2119498948A5051483672 @default.
• W2119498948 hasAuthorship W2119498948A5052851513 @default.
• W2119498948 hasAuthorship W2119498948A5053005053 @default.
• W2119498948 hasAuthorship W2119498948A5056409417 @default.
• W2119498948 hasAuthorship W2119498948A5091019309 @default.
• W2119498948 hasConcept C121608353 @default.
• W2119498948 hasConcept C126322002 @default.
• W2119498948 hasConcept C126838900 @default.
• W2119498948 hasConcept C141071460 @default.
• W2119498948 hasConcept C2777377203 @default.
• W2119498948 hasConcept C2777757722 @default.
• W2119498948 hasConcept C2778902805 @default.
• W2119498948 hasConcept C2779572924 @default.
• W2119498948 hasConcept C509974204 @default.
• W2119498948 hasConcept C530470458 @default.
• W2119498948 hasConcept C71924100 @default.
• W2119498948 hasConceptScore W2119498948C121608353 @default.
• W2119498948 hasConceptScore W2119498948C126322002 @default.
• W2119498948 hasConceptScore W2119498948C126838900 @default.
• W2119498948 hasConceptScore W2119498948C141071460 @default.
• W2119498948 hasConceptScore W2119498948C2777377203 @default.
• W2119498948 hasConceptScore W2119498948C2777757722 @default.
• W2119498948 hasConceptScore W2119498948C2778902805 @default.
• W2119498948 hasConceptScore W2119498948C2779572924 @default.
• W2119498948 hasConceptScore W2119498948C509974204 @default.
• W2119498948 hasConceptScore W2119498948C530470458 @default.
• W2119498948 hasConceptScore W2119498948C71924100 @default.
• W2119498948 hasIssue "4" @default.
• W2119498948 hasLocation W21194989481 @default.
• W2119498948 hasLocation W21194989482 @default.

• next